Other OTC - Delayed Quote USD

Nova Eye Medical Limited (ELXMF)

0.1000 0.0000 (0.00%)
At close: April 25 at 2:26 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Victor Previn B.E., B.Eng Founder & Executive Chairman 153.68k -- 1958
Mr. Thomas H. Spurling AM, BSc (Hons), FRACI, FTSE, Ph.D. MD & Executive Director 163.87k -- 1962
Liam Cook Chief Financial Officer -- -- --
Mr. Keith Byrne Vice President of Global Operations -- -- --
Mark Flynn Investor Relations -- -- --
Ms. Kate Hunt Head of Marketing -- -- --
Dr. David Lubeck M.D. Chief Medical Officer -- -- --
Mr. Joaquin V. Wolff President of Ellex iTrack -- -- 1958
Ms. Kimberley Menzies Group Financial Controller & Global Finance Manager -- -- --
Mr. Simon Jeremy Newton Gray BEc, C.A., CA Company Secretary -- -- 1959

Nova Eye Medical Limited

107 Rundle Street
Kent Town, SA 5067
Australia
61 8 8362 0193 https://www.nova-eye.com
Sector: 
Healthcare
Industry: 
Medical Devices

Description

Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It offers iTrack, a glaucoma surgical device to reduce intraocular pressure in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.

Corporate Governance

Nova Eye Medical Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Jul 21, 2020
    Ex-Dividend Date

Upcoming Events